UHS(UHS)
UHS
Q4 2026 EPS Estimate
$5.30
Oct 26, 2026 · Reports after close
Revenue Estimate
$4.72B
FY2026E EPS$22.63
FY2027E EPS$24.19
Analyst Sentiment
Wall St. Consensus
Hold22 analysts·High coverage
57
Score
8 Buy (36%)12 Hold (55%)2 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
836%
Hold
1255%
Sell
29%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$166.00
-2.4%
Consensus
$189.00
+11.2%
Bull
$290.00
+70.6%
12-Month Target Range22 analysts
$166.00$189.00$290.00
Current $170.02Consensus
Current Price
$170.02
Upside to Consensus
$18.98
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+4.89%
EPS+6.92%
FY2028
Rev+4.63%
EPS+10.58%
FY2029
Rev+3.93%
EPS-4.12%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $18.61B | $19.52B | $20.43B | $21.23B |
| Low | $18.47B | $19.20B | $19.39B | $20.70B |
| High | $18.75B | $19.75B | $21.11B | $21.68B |
| EBITDA Avg | $2.57B | $2.69B | $2.82B | $2.93B |
| Low | $2.55B | $2.65B | $2.67B | $2.86B |
| High | $2.59B | $2.72B | $2.91B | $2.99B |
| EBIT Avg | $1.83B | $1.92B | $2.01B | $2.09B |
| Low | $1.82B | $1.89B | $1.91B | $2.04B |
| High | $1.84B | $1.94B | $2.08B | $2.13B |
| Net Income Avg | $1.46B | $1.56B | $1.70B | $1.65B |
| Low | $1.44B | $1.48B | $1.57B | $1.60B |
| High | $1.48B | $1.63B | $1.82B | $1.70B |
| EPS Avg | $22.63 | $24.19 | $26.75 | $25.65 |
| Low | $22.32 | $23.02 | $24.32 | $24.82 |
| High | $22.91 | $25.27 | $28.27 | $26.36 |
| Analysts (Rev / EPS) | 14 / 10 | 14 / 11 | 13 / 8 | 11 / 5 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.72B | $4.77B | $4.74B | $4.85B | $4.96B | $5.03B | $4.98B | $5.10B |
| Low | $4.70B | $4.68B | $4.63B | $4.74B | $4.84B | $4.91B | $4.87B | $4.98B |
| High | $4.76B | $4.85B | $4.84B | $4.96B | $5.06B | $5.13B | $5.09B | $5.20B |
| EBITDA Avg | $651M | $658M | $654M | $670M | $684M | $693M | $687M | $703M |
| Low | $648M | $645M | $639M | $655M | $668M | $678M | $671M | $687M |
| High | $657M | $668M | $668M | $684M | $698M | $708M | $702M | $718M |
| EBIT Avg | $464M | $469M | $466M | $478M | $487M | $494M | $490M | $501M |
| Low | $462M | $460M | $456M | $467M | $476M | $483M | $479M | $490M |
| High | $468M | $477M | $476M | $488M | $498M | $505M | $500M | $512M |
| Net Income Avg | $318M | $344M | $361M | $371M | $348M | $389M | $382M | $399M |
| Low | $306M | $319M | $350M | $360M | $337M | $378M | $370M | $387M |
| High | $334M | $360M | $371M | $381M | $357M | $400M | $392M | $410M |
| EPS Avg | $5.30 | $5.75 | $6.02 | $6.18 | $5.80 | $6.49 | $6.37 | $6.65 |
| Low | $5.11 | $5.33 | $5.84 | $6.00 | $5.63 | $6.30 | $6.18 | $6.46 |
| High | $5.57 | $6.01 | $6.18 | $6.36 | $5.96 | $6.67 | $6.54 | $6.84 |
| Analysts (Rev / EPS) | 10 / 9 | 10 / 9 | 9 / 6 | 9 / 3 | 9 / 3 | 9 / 6 | 8 / 8 | 8 / 4 |